Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Zymeworks Inc ZYME

Healthcare Biotechnology
Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop differentiated antibody-based... see more

NDAQ:ZYME - Post Discussion

Zymeworks Inc > what's not to like about ZYME ?
View:
Post by ghayes on Nov 09, 2021 3:16pm

what's not to like about ZYME ?

Just came across this one - a long list of analysts are targeting it for $45 - $55,  and RJ are saying $74 !. ZYME Price Target, Analyst Ratings & Predictions (Zymeworks) (marketbeat.com)
The Company has a good stable of products in the pipeline,, Investor conference presentation coming up. The chart looks like bottoming out / about to turn... Hmmm. I'm in at 22.16 today.  keeping an eye on it.  I will be happy with $30..we shalll see
Comment by Gringotts on Nov 09, 2021 6:30pm
It is heartening to know someone is reading and posting on the Zyme billboard. By the way, I agree. The vast majority of shares are owned by investment companies.   The share price slide from the high $50's earlier this year was unnerving.  My fear is the company will be bought out for next to nothing. Hostile or through an offer.  If an offer of $44 were made today ...more  
Comment by ghayes on Nov 10, 2021 3:13am
Thanks gringotts,  after considering what you have said, I think I should get a few more. Will wait until I see an upward trajectory developing though.  If the Zyme rep made a good presentation at that conference,  there should be about a 3 or 4 day lag and then the attendees will be back selling it to their fund investment teams or suggesting it to their individual clients.  & ...more  
Zymeworks Inc